Characteristics and outcomes in hospitalized COVID-19 patients during the first 28 days of the spring and autumn pandemic waves in Milan: An observational prospective study. (March 2021)

• Record Type: Journal Article
• Authors: Radovanovic, Dejan; Pini, Stefano; Franceschi, Elisa; Pecis, Marica; Airoldi, Andrea; Rizzi, Maurizio; Santus, Pierachille
• Is Part Of: Respiratory medicine. Volume 178(2021)
• Publication Date: 2021-03
• Subjects: COVID-19 -- Respiratory failure -- Pneumonia -- Treatment -- CPAP -- Mortality; COVID-19 Coronavirus Disease 2019 -- CPAP Continuous Positive Airway Pressure -- CRP C reactive protein -- DNI do not intubate order -- ED emergency department -- FEU fibrinogen equivalent unit -- FiO2 inspired oxygen fraction -- HDRU high dependency respiratory unit -- Hb hemoglobin -- IMV invasive mechanical ventilation -- LDH lactic acid dehydrogenase -- LMWH Low Molecular Weight Heparin -- PaO2 peripheral arterial oxygen partial pressure -- PaCO2 peripheral arterial carbon dioxide partial pressure -- PEEP positive end expiratory pressure -- SaO2 peripheral oxygen saturation -- WBC white blood cells; Chest -- Diseases -- Periodicals; Chest -- Diseases -- Great Britain -- Periodicals; Respiratory organs -- Diseases -- Periodicals; Respiratory Tract Diseases -- Periodicals; Appareil respiratoire -- Maladies -- Périodiques; Thorax -- Maladies -- Périodiques; Appareil respiratoire -- Maladies -- Traitement -- Périodiques; Electronic journals; 616.2
• DOI: 10.1016/j.rmed.2021.106323
• Languages: English
• ISSNs: 0954-6111

Abstract

Abstract: Background: The therapeutic approach to COVID-19 and healthcare system preparedness improved during 2020. We compared characteristics and outcomes of hospitalized COVID-19 patients during the first 28 days of the March and October pandemic waves in Milan, Italy. Material and methods: A prospective, observational study enrolling adult patients hospitalized with COVID-19 pneumonia during March 7-April 4 (1st period) and October 15-November 12 (2nd period). During the 1st period hydroxychloroquine, lopinavir/ritonavir and therapeutic enoxaparin when thrombosis was confirmed were administered; systemic corticosteroids were given in case of severe pneumonia. During the 2nd period dexamethasone, methylprednisolone, remdesivir, thromboprophylaxis or anticoagulation were administered according to international recommendations. Patients with respiratory distress on oxygen masks initiated CPAP. Outcomes were: length of hospital stay, all-cause in-hospital mortality and need for intubation. Results: We included 70 patients (75% males) during the 1st and 76 patients (51% males, p = 0.522) during the 2nd period. Prevalence of severe respiratory failure (30% vs. 12%, p = 0.006), and D-dimer >3000 FEU (34% vs. 15%, P = 0.012) were reduced during the 2nd period, while anticoagulation and corticosteroids were more frequently administered (both p < 0.01). Mortality and time to referral were also reduced (39.4% vs. 22.4%, p = 0.019 and 6 vs. 5 days, p = 0.014), while need for intubation didn't change. Hospitalization length was comparable, but the proportion of patients discharged home was higher during the 2nd period (28.2% vs. 55.4%, p = 0.001). Conclusions: Changing treatment paradigms and early referral might have reduced mortality in COVID-19 patients. The effects of specific therapeutic regimens needs further confirmation in future clinical studies. Highlights: We compared patients' characteristics and outcomes during the 2020 1st and 2nd epidemic waves in Milan. The proportion of patients with severe respiratory failure was higher during the 1st period. Timing of referral and all-cause mortality were significantly decreased during the 2nd period. Higher social awareness and change in treatment regimens may have promoted better outcomes during the 2nd pandemic wave.